Investors:

Single-cell Analysis Market is predicted to grow at a CAGR of ~17.1%. The market is predicted to reach $2005 million in 2026 from $763.4 million in 2020. End-users of our proprietary cytometry-based research assays will be pharmaceutical and biotechnology companies, and the clinical assays will be integrated healthcare organizations.

Deepath Diagnostics seeks First Round Funding to support clinical validation of the technology and services. Potential Investors are encouraged to contact us.